Beyond Pain Management: A One Medicine Approach to Osteoarthritis with Guests Graham Lumsden and Jonathan Larkin

What happens when human health, animal health, and entrepreneurial drug development intersect?

In this episode of Fractals: Life Science Conversations, Bracken CEO Colin Miller is joined by Senior Partners Graham Lumsden, BVM&S, Dip.M., MRCVS, and Jonathan Larkin, PhD, to discuss osteoarthritis innovation, One Medicine, and the collaborative pathways that can move novel therapies forward.

Together, they discuss:

Why osteoarthritis remains a major unmet need in both human and animal health

How disease-modifying approaches could shift treatment beyond pain management

The promise of bispecific antibody development in addressing both pain and cartilage degeneration

How animal health studies can help inform human development programs, and vice versa

Why human expertise, networks, and scientific judgment remain essential in the age of AI

Tune in to Fractals on your preferred podcast platform, and reach out to Bracken to learn how we help life science teams connect strategy, science, and execution across development.